Products for Research Use Only
RegisterLogin

Linvoseltamab

CAT: 0804-HY-P9989-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P9989-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Linvoseltamab (REGN5458) is a bispecific T-cell engager (BiTE) antibody that specifically binds to B cell maturation antigen (BCMA) and CD3 of T cells, thereby directing T cells to multiple myeloma (MM) cells expressing BCMA and activating T cells to kill tumor cells. Linvoseltamab can be used in research of relapsed/refractory multiple myeloma (RRMM) [1][2][3].
CAS Number
2408319-25-3
Product Name Alternative
REGN5458
UNSPSC
12352203
Target
CD3; TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/linvoseltamab.html
Purity
99.71
Solubility
10 mM in DMSO|H2O
Smiles
[Linvoseltamab]
Molecular Weight
(145.51 kDa)
References & Citations
[1]Lee H C, et al. LINKER-MM1 study: Linvoseltamab (REGN5458) in patients with relapsed/refractory multiple myeloma[J]. 2023.|[2]Linvoseltamab. IMGT/mAb-DB.|[3]DiLillo DJ, et al., A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells. Blood Adv. 2021 Mar 9;5 (5) :1291-1304.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
abx831867-01Linvoseltamab
GTR18333968Linvoseltamab Antibody
HX959086-01Research Grade Linvoseltamab
E55B1299Linvoseltamab (Reference antibody)
A4019-1mgLinvoseltamab (Anti-BCMA & CD3)
GTR18697223-01Linvoseltamab Human Monoclonal Antibody
A135613Linvoseltamab Biosimilar (Monoclonal, IgG4-kappa)
BIO0976SM-1mgAnti-human BCMA & CD3 (Linvoseltamab Biosimilar)
GTR18699400-01Anti-BCMA & CD3 Reference Antibody (Linvoseltamab Biosimilar)
PX-TA1859-01Linvoseltamab Biosimilar - Anti-TNFRSF17 mAb - Research Grade

Popular Products